Biotech Investor Spotlight - Recent Interview with Mr. Stephen M. Simes, President and CEO of BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX)

by Investor Ideas, Benzinga Contributor
May 12, 2011 9:00 AM | 11 seconds read |
Point Roberts, WA, LINCOLNSHIRE, Ill - May 12, 2011 – Investorideas.com, a leader in sector stock research for independent investors, releases the following updates for featured showcase biotech/pharma stock BioSante Pharmaceuticals, Inc. BPAX.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: BiotechnologyHealth Care
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!